Evidence map›Paper›PMID 42360466›Full record

ReviewGraefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie2026

DMEK, DSAEK, and repeat PKP for endothelial failure after PKP: systematic review and meta-analysis with a graphical synthesis of clinical decision factors.

Giacomo Beschi, Yousef Youssef, Filippo Lozza, Mariantonia Ferrara, Vito Romano, Guillermo Rocha

Abstract readReview
PubMed Publisher
In one paragraph

Review in Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Giacomo Beschi *Department of Ophthalmology & Visual Sciences, McGill University, Montreal, Canada. g.beschi006@unibs.it.ORCID http://orcid.org/0009-0005-1815-7545
Yousef Youssef *Faculty of Medicine and Health Sciences, McGill University, Montreal, Canada.
Filippo LozzaDepartment of Medical and Surgical Specialties, Radiological Sciences, and Public Health, University of Brescia, Brescia, Italy.
Mariantonia FerraraDepartment of Medical and Surgical Specialties, Radiological Sciences, and Public Health, University of Brescia, Brescia, Italy.
Vito RomanoDepartment of Medical and Surgical Specialties, Radiological Sciences, and Public Health, University of Brescia, Brescia, Italy.
Guillermo RochaDepartment of Ophthalmology & Visual Sciences, McGill University, Montreal, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo compare outcomes of Descemet membrane endothelial keratoplasty (DMEK), Descemet stripping automated endothelial keratoplasty (DSAEK), and repeat penetrating keratoplasty (re-PKP) performed for endothelial failure after penetrating keratoplasty (PKP), and to summarize the clinical factors that appear to influence procedure selection.

methodsA review and meta-analysis was conducted using a preregistered protocol. Studies reporting outcomes of DMEK, DSAEK, or re-PKP for post-PKP endothelial failure were included. A systematic search was conducted in MEDLINE (via PubMed), Embase, and the Cochrane Library from inception. Pooled proportions were calculated for graft failure, rejection, and detachment. Eligible studies included original clinical studies of adult eyes with endothelial failure after prior PKP undergoing DMEK, DSAEK, or re-PKP, with at least five post-PKP eyes in a relevant treatment arm and reporting at least one outcome of interest. Visual acuity (VA) was synthesized as weighted means with bootstrap confidence intervals at predefined timepoints (preoperative, 3-5 months, 6 months, 12-13 months). Clinical decision factors were summarized descriptively and graphically. Risk of bias was assessed using the Joanna Briggs Institute checklist for case series and ROBINS-I V2 for comparative non-randomized studies.

resultsThirty-two studies met inclusion criteria, consisting predominantly of retrospective case series, with a smaller number of prospective or comparative observational studies. Pooled failure rates were 0.22 for DMEK, 0.19 for DSAEK, and 0.29 for re-PKP. Rejection was lowest after DMEK (0.07) and higher after DSAEK (0.14) and re-PKP (0.15). Detachment occurred more frequently after DMEK (0.37) than DSAEK (0.18). All three procedures improved VA relative to baseline. DMEK showed numerically greater and more sustained improvement through 12-13 months, whereas DSAEK and re-PKP improved early and then stabilized; however, these findings are descriptive and should be interpreted with caution given differences in baseline visual acuity and follow-up across studies. Several clinical factors-including the initial PKP indication, pre-existing glaucoma, and prior glaucoma surgery-were variably associated with procedure choice, but reporting was inconsistent.

conclusionsDMEK, DSAEK, and re-PKP all improve vision after endothelial failure of a prior PKP but differ in complication profiles and in the trajectory of visual recovery. DMEK showed numerically greater visual acuity improvement and the lowest pooled rejection proportion, albeit with a higher pooled detachment proportion. Current evidence is limited by incomplete reporting of preoperative and graft-related variables, the predominance of retrospective non-randomized studies, and variable risk of bias across included studies, constraining the ability to derive a consistent decision framework.

Indexed as

Descemet membrane endothelial keratoplasty (DMEK)Descemet stripping automated endothelial keratoplasty (DSAEK)Endothelial failureEndothelial keratoplastyGraft failurePenetrating keratoplasty (PKP)Repeat keratoplasty

Identifiers

PMID42360466

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.